Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04769492 · ClinicalTrials.gov registry record · NA

#ChopViolence/#ChopHIV

A NA study of HIV and Violence, sponsored by Hektoen Institute for Medical Research.

Recruiting
Registry status
NA
Development phase
525
Enrollment target
1
Study location

NCT04769492: Recruiting NA study of HIV and Violence, sponsored by Hektoen Institute for Medical Research.

NCT04769492 is a NA study of HIV and Violence that is actively recruiting participants, run by Hektoen Institute for Medical Research. The registered enrollment target is 525 participants, above the 438-participant average among 303 other HIV trials with a reported enrollment target (20% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04769492, a NA study of HIV and Violence, is actively recruiting participants, sponsored by Hektoen Institute for Medical Research.

RECRUITING
Registry status
NA
Development phase
525 participants
Enrollment target
1
Study location

Study Summary

Black young gay, bisexual and other men who have sex with men (B-YGBMSM) and transgender women (B-YTW) are disproportionately affected by HIV/AIDS in the U.S. Youth in the House Ball Community (HBC), a subculture of the Black gay community that offers a social network to freely express diverse sexual and gender identities, are among the most at-risk for HIV infection and loss to care, but barriers exist to the provision of HIV services within this community. One barrier is the increasing rates of violence. Interventions are needed that will interrupt the cycle of violence within the HBC to allow for adequate provision of HIV services and increased access to HIV care. The investigators propose to tailor the Cure Violence model for violence prevention for developmental-appropriateness, cultural-specificity and HIV relevance, then pilot test the new intervention (#ChopViolence/#ChopHIV) with B-YGBMSM and B-TW in the Chicago HBC. The proposed research activities will take place in six steps. In Step 1, the investigators will hold Youth Advisory Board meetings, finalize our assessment battery and conduct multiple baseline assessments (months 3, 9 \& 15; n=75 per assessment point) at HBC venues to track trends in violence (i.e., intimate partner, HBC and neighborhood violence), HIV stigma, substance use, mental health, sexual risk and HIV care engagement. In Step 2, the investigators will employ ADAPT-ITT strategies for adapting evidence-based interventions including conducting a series of focus groups (n=32) with youth and leaders from the HBC in order to identify persuasive messaging around decreasing violence and improving HIV outcomes. Based on the focus group data as well as consultation with community experts, the investigators will then tailor the intervention to be relevant for the Chicago HBC and develop training materials along with standard operating procedures. In Step 3, the investigators will identify, recruit and train trusted members of the HBC to work as

Conditions Studied

Interventions

  • OTHER #ChopViolence/#ChopHIV

Study Locations (1)

Illinois

  • Cook County Health - Chicago

Trial Details

FieldValue
Enrollment Target 525 participants
Start Date 2020-07-30
Est. Completion 2024-08-30
Phase NA

What NCT04769492 shows while recruiting

NCT04769492 is an interventional study that assigns participants to a tested intervention. The registered 525 participants enrollment target is mid-sized for trials with a published cap, above the 438-participant average among 303 other HIV trials with a reported enrollment target (20% higher).

The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which #ChopViolence/#ChopHIV is the first listed.

NCT04769492 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT04769492 about?

NCT04769492 is a clinical study titled "#ChopViolence/#ChopHIV". Black young gay, bisexual and other men who have sex with men (B-YGBMSM) and transgender women (B-YTW) are disproportionately affected by HIV/AIDS in the U.S. Youth in the House Ball Community (HBC), a subculture of the Black gay community that offers a social network to freely express diverse sexua...

What is the current status of trial NCT04769492?

This trial is currently recruiting. It is a NA study. The enrollment target is 525 participants. The study started on 2020-07-30. Estimated completion is 2024-08-30.

What conditions does trial NCT04769492 study?

This clinical trial studies the following conditions: HIV, Violence.

What interventions are being tested in trial NCT04769492?

The interventions under investigation include: #ChopViolence/#ChopHIV (OTHER).

Who is sponsoring clinical trial NCT04769492?

This trial is sponsored by Hektoen Institute for Medical Research, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04769492 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04769492's enrollment target sits among peer trials

525 34th of 303 higher than 270 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05260047 · 525 participants · NA

    Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population

  • NCT05620719 · 525 participants · NA

    Multisite Advancement of Research on Chronic Posttraumatic Headache

  • NCT06496646 · 525 participants · NA

    Antidepressant Adherence for Depressed Adults in Primary Care

  • NCT04738825 · 526 participants · NA

    Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With PrEP Adherence and Support Services

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04769492, the US trial registry maintained by the National Library of Medicine. NCT04769492 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.